Federal jurors in Delaware found that Amgen violated antitrust laws by bundling its cholesterol treatment with substantial ...

"The trust issues are quite far-reaching" and impact public perception towards health-based changes across the U.S., a health professor told Newsweek.

Additionally, the Department of Health and Human Services unveiled the framework for the Most Favored Nation drug pricing ...

The Conversation asked Nicole Hassoun, a professor at Binghamton University and executive director of Global Health Impact, to explain the pandemic accord, its prospects for advancing global health, ...

The notice from Nasdaq indicates that the Company is in compliance with the Nasdaq Capital Market's listing requirements and the Company's common stock will continue to be listed and traded on Nasdaq.

U.S. prices for newly-launched pharmaceuticals more than doubled last year compared to 2021, as companies leveraged ...